ArticleVaccines2024

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans.

Alina Tscherne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.